Mississippi's State Board of Clinical Licensure now prohibits prescribing, dispensing, or administrating compounded semaglutide for weight reduction, citing safety fears, but legal guidelines change from condition to condition. Shoppers can consult with the FDA's BeSafeRx marketing campaign